Home/Pipeline/Cingal

Cingal

Osteoarthritis Pain (Knee)

CommercialApproved ex-U.S.

Key Facts

Indication

Osteoarthritis Pain (Knee)

Phase

Commercial

Status

Approved ex-U.S.

Company

Anika Therapeutics

About Anika Therapeutics

Anika Therapeutics is a mission-driven company focused on redefining orthopedic care through innovative, non-opioid, hyaluronic acid-based solutions. The company has achieved a global commercial footprint with a portfolio of regenerative scaffolds and viscosupplements, strategically partnered with J&J MedTech for key U.S. sales. Its strategy centers on leveraging a deep proprietary HA technology platform to expand indications, enhance existing products, and address the large, growing market for minimally invasive musculoskeletal treatments.

View full company profile

Therapeutic Areas

Orthopedic Regenerative Medicine Osteoarthritis Pain Management

Other Osteoarthritis Pain (Knee) Drugs

Drug	Company	Phase	Status
Monovisc	Anika Therapeutics	Commercial	Marketed globally
Orthovisc	Anika Therapeutics	Commercial	Marketed globally